X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster
Investing in India? Get Equitymaster Research  
Indian market indices open weak 
(Fri, 8 Jun 09:30 am) 
 
Most Asian stock markets have opened the day on a weak note with stock markets in Japan (down 1.6%) and Taiwan (down 0.9%) leading the losses in the region. The Indian equity market indices have also opened the day on a negative note. Stocks in the consumer durables and auto space are leading the pack of losers.

The Sensex today is down by around 94 points (0.6%), while the NSE-Nifty is down by around 31 points (0.6%). Mid and small cap stocks are also trading in the red with the BSE Mid cap and BSE Small cap indices down by around 0.5% and 0.2% respectively. The rupee is trading at Rs 55.16 to the US dollar.

Indian pharma stocks have opened the day on a mixed note with Indoco Remedies, Wockhardt and Ranbaxy Laboratories trading firm. However, Glenmark Pharmaceuticals and Orchid Chemicals are facing selling pressure. Indian drug maker Dr Reddy's Laboratories has launched ropinirole hydrochloride XR tablets in the US market. These tablets are the bioequivalent generic version of Requip XL tablets which is a registered trademark of pharma company SmithKline Beecham. The drug is used to treat the signs and symptoms of Parkinson's disease. Dr Reddy's has received the approval from US Food & Drug Administration (FDA) for its abbreviated new drug application for ropinirole hydrochloride XR tablets to launch a generic product. As per IMS Health, Requip XL had reported sales of about US$ 58 m for the financial year ended March 2012 in the US market.

FMCG stocks have also opened the day on a mixed note with Hindustan Unilever Ltd(HUL) and Colgate trading in the green. However, Godrej Consumer Products Ltd (GCPL) and P&G Hygiene are trading weak. As per a leading financial daily, India's largest FMCG firm HUL is planning to extend its Lux brand into the deodorant segment. India will become the only country where the world's largest selling soap brand will be launched as a deodorant. The size of India's fast growing deodorant market is estimated to be about Rs 13 bn. HUL already has a dominant market share in the male deodorant space with its Axe brand being the largest selling deodorant in India. Recently, the company also launched a range of body sprays under the brand name Denim.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives  RSS
Read the latest Market Commentary
 
BSE-30
 

 
Go
 

Equitymaster requests your view! Post a comment on "Indian market indices open weak". Click here!

  
 

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

S&P BSE SENSEX


Jul 24, 2017 12:11 PM

MARKET STATS